Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Radix BioSolutions provides custom assay method development and kit manufacturing services to support biopharmaceutical R&D, infectious disease monitoring, and environmental agent identification. The company specializes in large molecule assay development—including ligand binding assays—critical reagent manufacturing and labeling at scale. They are recognized for rapid turnaround times and high-quality products validated with certificates of analysis. Their expertise includes Luminex xMAP technology, ELISA-based methods, oligonucleotide-supporting assays, nanotechnology-based detection systems, and both regulated/non-regulated study support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Radix BioSolutions.